Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI (ADMET) | = 96 % | Cytotoxicity against human HEK293 cells at 120 uM after 72 hrs by Alamar blue assay | ChEMBL. | 19591451 |
IC50 (functional) | = 9.9 uM | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs by DAPI staining method | ChEMBL. | 19591451 |
IC50 (functional) | = 11.4 uM | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum Dd2 after 72 hrs by DAPI staining method | ChEMBL. | 19591451 |
IC50 (functional) | > 30 uM | Cytotoxicity against human AGS cells by MTS colorimetric assay | ChEMBL. | 11087586 |
IC50 (functional) | > 30 uM | Cytotoxicity against human DLD1 cells by MTS colorimetric assay | ChEMBL. | 11087586 |
IC50 (functional) | > 30 uM | Cytotoxicity against human HepG2 cells by MTS colorimetric assay | ChEMBL. | 11087586 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 19591451 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.